Trial record 1 of 2 for:    The Worldwide Sarcoidosis Research Study
Previous Study | Return to List | Next Study

Worldwide Sarcoidosis Research Study (WISE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2015 by University of Iowa
National Center for Research Resources (NCRR)
Information provided by (Responsible Party):
Alicia Gerke, University of Iowa Identifier:
First received: May 31, 2012
Last updated: May 27, 2015
Last verified: May 2015

The aim of this study is to collect information about the clinical course and characteristics of sarcoidosis patients around the world through web-based surveys. Recruitment is directed at and driven by patients in the sarcoidosis community. This will allow the the investigators to study sarcoidosis patients across all demographic, geographic, and socioeconomic boundaries, not just patients seen at large research centers. The investigators believe this study can give investigators a broader and less biased view of sarcoidosis. The investigators would also like to collect genetic samples on this population to assess genetic variance in different phenotypes.

The information for the study would be provided through a web based survey system that can be accessed by patients or physicians of patients from any computer with Internet access. This system would collect clinical information in sufficient detail so that the phenotype of individual patients can be evaluated. Upon agreeing to participate in further research studies through the website, subjects will also have the opportunity to provide a DNA sample.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Worldwide Sarcoidosis Research Study

Resource links provided by NLM:

Further study details as provided by University of Iowa:

Primary Outcome Measures:
  • Define and characterize sarcoidosis phenotypes and methods of care [ Time Frame: Anticipated by 2017 ] [ Designated as safety issue: No ]
    To give a broader and less biased view of sarcoidosis

Biospecimen Retention:   Samples With DNA
Saliva samples will be collected and processed at the University of Iowa.

Estimated Enrollment: 10000
Study Start Date: December 2011
Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Individuals diagnosed with sarcoidosis who have a computer with Internet access.

Inclusion Criteria:

  • Diagnosis of Sarcoidosis
  • Access to a computer with Internet

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01610843

Contact: Alicia K Gerke, MD 319-356-1869
Contact: Emily K Phillips, BSN 319-356-1869

United States, Iowa
University of Iowa Recruiting
Iowa City, Iowa, United States, 52242
Contact: Alicia K Gerke, MD    319-356-1869   
Sub-Investigator: Alicia K Gerke, MD         
Sponsors and Collaborators
University of Iowa
National Center for Research Resources (NCRR)
Principal Investigator: Alicia K Gerke, MD University of Iowa
  More Information

Additional Information:

Responsible Party: Alicia Gerke, Assistant Professor; Division of Pulmonary, Critial Care and Occupational Medicine, University of Iowa Identifier: NCT01610843     History of Changes
Other Study ID Numbers: 200907757  5UL1RR024979 
Study First Received: May 31, 2012
Last Updated: May 27, 2015
Health Authority: United States: Institutional Review Board

Keywords provided by University of Iowa:
Sarcoid Study
Worldwide Sarcoidosis Research Study

Additional relevant MeSH terms:
Lymphatic Diseases
Lymphoproliferative Disorders processed this record on May 26, 2016